1. Home
  2. OI vs RCKT Comparison

OI vs RCKT Comparison

Compare OI & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo O-I Glass Inc.

OI

O-I Glass Inc.

SELL

Current Price

$4.78

Market Cap

932.7M

ML Signal

SELL

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

SELL

Current Price

$2.06

Market Cap

277.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OI
RCKT
Founded
1903
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
932.7M
277.7M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
OI
RCKT
Price
$4.78
$2.06
Analyst Decision
Buy
Buy
Analyst Count
8
14
Target Price
$6.50
★ $8.82
AVG Volume (30 Days)
★ 4.0M
1.6M
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 26.37
EPS
N/A
★ 0.23
Revenue
★ $6,426,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.68
$1,494.26
P/E Ratio
★ N/A
$9.43
Revenue Growth
N/A
★ N/A
52 Week Low
$4.75
$2.15
52 Week High
$16.91
$5.45

Technical Indicators

Market Signals
Indicator
OI
RCKT
Relative Strength Index (RSI) 32.45 34.77
Support Level N/A N/A
Resistance Level $5.62 $2.73
Average True Range (ATR) 0.30 0.18
MACD -0.05 -0.02
Stochastic Oscillator 6.59 8.59

Price Performance

Historical Comparison
OI
RCKT

About OI O-I Glass Inc.

O-I Glass is the manufacturer of glass containers. The Company has two reportable segments and two operating segments based on its geographic locations: Americas and Europe. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: